. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
Microsoft Word - NWR 93-62_E_Q1 (Translation) No.FN-NWR 093/62 14 May 2019 Subject : Submission of Financial Statements for the first quarter ended March 31,2019 To : President The Stock Exchange of
(Translation) NEP-AC 002/2562 15 May 2019 Subject: Management Discussion and Analysis for 1st Quarter ended 31 March 2019 To : The President The Stock Exchange of Thailand Operating Result NEP Realty
period of 2018 To : The President of the Stock Exchange of Thailand The Company would like to provide details of changes in Profit and Loss as shown in the six-month period ending 30 June 2019 reviewed
[COMPANY NAME] Ref.:EFORL020/2018 May 15, 2018 Subject: Management Discussion and Analysis for the first quarter ended 31 March 2018 To President The Stock Exchange of Thailand 1. Overview financial
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
) August 8, 2018 Re : Report the operating result for the year ended June 30 ,2018 by more than 20 percent. To : Director and Manager the Stock Exchange of Thailand Approved by the Board of Directors of
Microsoft Word - MD&A 2Q2018 EN Final 15082018 Ref.:EFORL035/2018 August 15, 2018 Subject: Management Discussion and Analysis for the first quarter ended 30 June 2018 To President The Stock Exchange
Manager The Stock Exchange of Thailand The Board of Directors Meeting of O.C.C. Public Company Limited No. 5/2561 held on October 17, 2018 had resolved to approve the purchase of ordinary shares of Shop
and Analysis Quarterly Ending September 30, 2018 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 4/2018